Rugo Surveys Peers on Treatment After Metastatic Relapse of HR+, HER2– Breast Cancer
During a Case-Based Roundtable® event, Hope S. Rugo, MD, FASCO, moderated a discussion on treatment options for a patient whose breast cancer recurred several years after adjuvant therapy.